ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
新加坡股
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
科兴生物
6.47
0.0000
成交量:
- -
成交额:
- -
市值:
3.89亿
市盈率:
6.66
高:
6.47
开:
6.47
低:
6.47
收:
6.47
数据加载中...
总览
公司
新闻
公告
科兴甲型乙型肝炎联合疫苗倍尔来福再注册上市
格隆汇
·
07-31
争夺疫苗之王
中金在线
·
07-28
89亿美元巨额分红背后:科兴生物九年“内斗”将如何收场?
澎湃新闻
·
07-26
李嘉强方面表态:探索科兴生物未来在港交所上市,自己无意长期担任董事长职位
财经网
·
07-25
知情人士:解决科兴“内斗”应以谈为主 科兴生物董事长李嘉强称尹卫东是个好CEO
蓝鲸财经
·
07-24
【爱建医药】创新药主线强势回归,关注BigPharma管线价值重估
爱建证券研究所
·
07-22
科兴生物争夺记:谁能打开百亿美元“金库”大门?
每日经济新闻
·
07-21
十年内斗未休,科兴生物滑向退市
法治日报
·
07-17
科兴“宫斗”背后,第一大股东强新资本的算盘
第一财经
·
07-16
科兴生物内斗漩涡:九年纷争何时落幕?又将走向何方?
21世纪经济报道
·
07-16
科兴生物75亿美元“清仓式分红”背后:十年内斗掏空现金储备 研发停滞退市风险激增
华夏时报
·
07-12
一年挣960亿,印钞机都不如它卖力
老斯基财经
·
07-11
一周医药速览(07.07-07.11)
财经网
·
07-11
科兴内斗:十年血战未休
深科技
·
07-10
科兴生物新当选董事召开首次董事会会议
美国商业资讯
·
07-10
科兴生物商业版图盘点
和讯网
·
07-10
10位新董事上任,科兴生物特别股东大会通过赛富议案
广州日报
·
07-10
疫苗之王科兴生物拟分红近540亿!张雪峰灵魂拷问:要给哪国的股民发我们当年的钱
快科技
·
07-10
科兴生物特别股东大会选举10位新董事;多家医药上市公司发半年度预增公告 | 医药早参
每日经济新闻
·
07-10
每股分红55美元 科兴生物出现“清仓式”分红计划
中科财经
·
07-09
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/SVA/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SVA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SVA\",,,,,undefined,":{"symbol":"SVA","market":"US","secType":"STK","nameCN":"科兴生物","latestPrice":6.47,"timestamp":1754510400000,"preClose":6.47,"halted":3,"volume":0,"delay":0,"floatShares":31169000,"shares":60060702,"eps":0.971025,"marketStatus":"停牌","change":0,"latestTime":"08-06 16:00:00 EDT","open":6.47,"high":6.47,"low":6.47,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.971025,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1754553600000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1102482000000,"exchange":"NASDAQ","adjPreClose":6.47,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SVA\",,,,,undefined,":{"symbol":"SVA","floatShares":31169000,"roa":"11.46%","roe":"25.15%","lyrEps":1.055174,"shares":60060702,"dividePrice":0,"high":6.47,"amplitude":0,"preClose":6.47,"low":6.47,"week52Low":6.47,"pbRate":"0.52","week52High":6.47,"institutionHeld":0.0546,"latestPrice":6.47,"eps":0.971025,"divideRate":0,"volume":0,"delay":0,"ttmEps":0.971025,"open":6.47,"prevYearClose":6.47,"prevWeekClose":6.47,"prevMonthClose":6.47,"prevQuarterClose":6.47,"fiveDayClose":6.47,"twentyDayClose":6.47,"sixtyDayClose":6.47},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SVA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2555883641","title":"科兴甲型乙型肝炎联合疫苗倍尔来福再注册上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2555883641","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555883641?lang=zh_cn&edition=fundamental","pubTime":"2025-07-31 17:36","pubTimestamp":1753954618,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2554722183","title":"争夺疫苗之王","url":"https://stock-news.laohu8.com/highlight/detail?id=2554722183","media":"中金在线","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554722183?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 17:06","pubTimestamp":1753693593,"startTime":"0","endTime":"0","summary":"据说尹卫东那时决心:要做一个便宜的,中国孩子用得起的高品质疫苗。后来怡安研发的甲肝灭活疫苗获得新药证书,填补了国内空白。潘总十分赏识乡村医生尹卫东,还借给了尹卫东500万元,帮助其完成了甲肝疫苗的临床试验。2002年,甲肝灭活疫苗实现量产上市,从此中国甲肝疫苗不再仅依赖进口。但因为董事会成员拥有一票否决权,这个举措在当时并未遭受质疑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728172154a6c5b2ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728172154a6c5b2ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1543694498.USD","BK4139","IE00BN0W2V16.EUR","LU2041044095.USD","LU1721428933.USD","LU1165135440.EUR","BK4585","LU0347712357.USD","LU2092937221.SGD","BK4588","SVA","LU2413666426.HKD","A","BK4567","BK4121","LU2413666699.HKD","LU2229751404.USD","LU2089279066.USD","IE00BN0W2T93.GBP","IE00BN0W2W23.USD"],"gpt_icon":0},{"id":"2554715130","title":"89亿美元巨额分红背后:科兴生物九年“内斗”将如何收场?","url":"https://stock-news.laohu8.com/highlight/detail?id=2554715130","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554715130?lang=zh_cn&edition=fundamental","pubTime":"2025-07-26 14:51","pubTimestamp":1753512672,"startTime":"0","endTime":"0","summary":"因为一场巨额分红,科兴生物重回舆论焦点。7月10日,科兴生物宣布,来自赛富基金的阎焱当选为董事会主席。对于上述情况,7月9日,科兴生物另一个以李嘉强为代表的董事会称,此次股东大会“不合法”。光鲜的另一面是自2016年宣布美股私有化计划以来,科兴生物已陷入“内斗”九年。判决书显示,杭州强新生物科技有限公司判将非法占有的厦门未名34%股权返还至未名医药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726150839a4646a7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726150839a4646a7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2554878086","title":"李嘉强方面表态:探索科兴生物未来在港交所上市,自己无意长期担任董事长职位","url":"https://stock-news.laohu8.com/highlight/detail?id=2554878086","media":"财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554878086?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 03:09","pubTimestamp":1753384144,"startTime":"0","endTime":"0","summary":"近日,关于科兴生物的控制权争议出现新进展。据了解,现任董事会已于7月15日向纳斯达克提交合规整改方案,解决科兴生物控股退市风险。另据接近李嘉强方面的知情人士表示,现任董事长李嘉强无意长期担任董事长职位,愿意在未来只保留董事席位,前提是科兴生物控股组成一个符合公司发展且具有治理经验的董事会,确保科兴普通股股东能有公平的待遇,尽快终结科兴的纷争。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725031154a461c650&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725031154a461c650&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2553206188","title":"知情人士:解决科兴“内斗”应以谈为主 科兴生物董事长李嘉强称尹卫东是个好CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2553206188","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553206188?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 17:53","pubTimestamp":1753350790,"startTime":"0","endTime":"0","summary":"谈及科兴创始人之一的尹卫东,上述知情人士称,李嘉强与其已认识十五年。据了解,中间打官司的这些年,两人也有见面,围绕科兴的治理问题,双方所代表的董事会有利益冲突,也有过一些误解,但李嘉强还是认为“尹卫东是一个很好的CEO”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072417550494b8039a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072417550494b8039a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2553283847","title":"【爱建医药】创新药主线强势回归,关注BigPharma管线价值重估","url":"https://stock-news.laohu8.com/highlight/detail?id=2553283847","media":"爱建证券研究所","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553283847?lang=zh_cn&edition=fundamental","pubTime":"2025-07-22 09:23","pubTimestamp":1753147434,"startTime":"0","endTime":"0","summary":"WEEKLY REPORT创新药主线强势回归,关注BigPharma管线价值重估-爱建生物医药行业周报-本报告发布于2025年07月21日投资要点:医药板块跑赢沪深300,创新药再度强势回归。创新药主线强势回归、关注BigPharma管线价值重估。创新药再度领涨,仅线下药店回调。本周创新药出海主线强势回归,我们看好的PD-1双抗、ADC出海核心赛道均有亮眼表现。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722095530a6b97362&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722095530a6b97362&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688301","BK4505","BK4568","688293","600276","LU2417539215.USD","LU0889565916.HKD","01877","01177","BK4585","09995","688131","LU2456880835.USD","LU2462157665.USD","02359","TIL","AZN","603259","LU1829250122.USD","01276","688133","SBHMY","SVA","688062","09606","688180","688520","02696","09926","688105","01093","688271","02157","BK4588","01541","LU0320765992.SGD","BK4007","06821","688114","LU0109394709.USD","688331","02268","LU2236285917.USD","BK4139"],"gpt_icon":0},{"id":"2553554408","title":"科兴生物争夺记:谁能打开百亿美元“金库”大门?","url":"https://stock-news.laohu8.com/highlight/detail?id=2553554408","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553554408?lang=zh_cn&edition=fundamental","pubTime":"2025-07-21 22:41","pubTimestamp":1753108869,"startTime":"0","endTime":"0","summary":"经过股东多年缠斗,科兴生物如同一座埋藏着百亿美元的金库。今年7月,科兴生物突然宣布向全体股东派发总额74.48亿美元分红,首期每股55美元将在前述特别股东大会召开前“闪电”支付;二、三期合计最高每股124美元。根据科兴生物方面7月10日发布的信息,每股普通股55美元的特别现金股息已在向科兴生物的合法股东派发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721224208a6b864d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721224208a6b864d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2552896634","title":"十年内斗未休,科兴生物滑向退市","url":"https://stock-news.laohu8.com/highlight/detail?id=2552896634","media":"法治日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552896634?lang=zh_cn&edition=fundamental","pubTime":"2025-07-17 19:45","pubTimestamp":1752752737,"startTime":"0","endTime":"0","summary":"7月16日,在科兴生物美股退市警报拉响之际,市场传出其正谋求港股上市的消息。在新冠疫情期间,凭借克尔来福疫苗全球接种量超28亿剂,科兴生物成为了“赢家”。由于科兴生物长期陷入内斗,审计机构出于风险考量早已撤离,这一状况直接导致科兴生物2024年年报至今难产。停牌超过6年的科兴生物,早已元气殆尽。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717195029a6afc35d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717195029a6afc35d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2551126212","title":"科兴“宫斗”背后,第一大股东强新资本的算盘","url":"https://stock-news.laohu8.com/highlight/detail?id=2551126212","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551126212?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 21:59","pubTimestamp":1752674397,"startTime":"0","endTime":"0","summary":"目前,李嘉强控制的强新资本与关联公司持有科兴生物约三分之一的股份,是科兴生物的第一大股东。接近此事件的人士表示,他希望终结这场“宫斗”的一个重要的原因,是为了转移精力,推动强新科技原创药的研发上市。目前尚不清楚强新科技未来是否会寻求新的资本。2022年,潘爱华入狱,李嘉强正式踏入科兴股权争夺的中心。目前,双方的争议仍在持续中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507162200499544f1a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507162200499544f1a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2551125501","title":"科兴生物内斗漩涡:九年纷争何时落幕?又将走向何方?","url":"https://stock-news.laohu8.com/highlight/detail?id=2551125501","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551125501?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 20:59","pubTimestamp":1752670759,"startTime":"0","endTime":"0","summary":"另据上述知情人士透露,科兴生物小股东部分的分红已基本到账;大股东及争议股份对应款项暂存共管账户。市场对于强新资本方增持科兴生物的目的以及合法性争议。在2016年3月,科兴生物宣布其通过了“毒丸计划”。然而,2025年4月22日,科兴生物管理层发表声明称,目前董事会与英国枢密院裁决确认的名单并不相符。值得注意的是,科兴生物于2019年2月22日宣布,收到纳斯达克发出的暂停交易通知。自此以来,科兴生物已经停牌超过6年之久。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716210300a44ed16b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716210300a44ed16b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2550990429","title":"科兴生物75亿美元“清仓式分红”背后:十年内斗掏空现金储备 研发停滞退市风险激增","url":"https://stock-news.laohu8.com/highlight/detail?id=2550990429","media":"华夏时报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550990429?lang=zh_cn&edition=fundamental","pubTime":"2025-07-12 20:10","pubTimestamp":1752322248,"startTime":"0","endTime":"0","summary":"【科兴生物75亿美元“清仓式分红”背后:十年内斗掏空现金储备 研发停滞退市风险激增】被资本市场称为“疫苗行业世纪对决”的博弈,在7月9日加勒比海岛国安提瓜和巴布达的特别股东大会上达到高潮。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202507123455332375.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202507123455332375.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2550567129","title":"一年挣960亿,印钞机都不如它卖力","url":"https://stock-news.laohu8.com/highlight/detail?id=2550567129","media":"老斯基财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550567129?lang=zh_cn&edition=fundamental","pubTime":"2025-07-11 20:01","pubTimestamp":1752235298,"startTime":"0","endTime":"0","summary":"2021年至2022年,科兴控股营收超1300亿元,净利超960亿元。960亿是什么概念?960个亿哪怕对全球顶级富豪来说,都不是一个小数目。这要换成现金点一遍,点钞机都要被干冒烟。第二年4月16日,世卫组织公布SARS是由冠状病毒引起的。结果是,方案被有关部门采纳了。2004年1月19日,疫苗被批准进入临床试验。其实2003年8月16日,北京最后两名非典患者出院,就意味着咱们的SARS疫情结束了。终究,世界会给单纯的人一个大大的回报,比如一年960亿。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711203912a444e3c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711203912a444e3c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2550987149","title":"一周医药速览(07.07-07.11)","url":"https://stock-news.laohu8.com/highlight/detail?id=2550987149","media":"财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550987149?lang=zh_cn&edition=fundamental","pubTime":"2025-07-11 16:27","pubTimestamp":1752222452,"startTime":"0","endTime":"0","summary":"目前,市场上可用于小儿便秘的同类产品主要用于其他疾病伴发的便秘症状,临床尚无治疗小儿便秘的儿童专用中药创新药。甘李药业:预计上半年净利润增加100.73%到114.12%,胰岛素量价齐升甘李药业发布2025年半年度业绩预增公告。披露经财务部门初步测算,预计 2025 年半年度实现归属净利润为6亿元到6.4亿元,与上年同期相比,同比增加 100.73%到 114.12%。临床前多种动物模型研究结果显示,UBT37034与GLP-1类似物联用能显著降低体重。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711162815a44457d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711162815a44457d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600566","BK4139","SVA","01801","06855","03933","603087"],"gpt_icon":0},{"id":"2550640582","title":"科兴内斗:十年血战未休","url":"https://stock-news.laohu8.com/highlight/detail?id=2550640582","media":"深科技","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550640582?lang=zh_cn&edition=fundamental","pubTime":"2025-07-10 19:38","pubTimestamp":1752147481,"startTime":"0","endTime":"0","summary":"科兴生物控制权之争:十年博弈与天价分红背后的暗流科兴生物十年宫斗炸穿天际!图源:科兴生物二、2016:私有化计划引爆控制权争夺战2016 年,科兴生物提出私有化退市并回归内地上市的计划,这一决策成为矛盾爆发的导火索。这场围绕私有化路径的分歧,标志着科兴生物的内斗从隐性走向公开,进入白热化阶段。双方围绕公司治理、审计机构聘任等问题展开新一轮较量,科兴生物的控制权再次陷入不确定状态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710200807a4429238&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710200807a4429238&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2550440624","title":"科兴生物新当选董事召开首次董事会会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2550440624","media":"美国商业资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550440624?lang=zh_cn&edition=fundamental","pubTime":"2025-07-10 15:25","pubTimestamp":1752132300,"startTime":"0","endTime":"0","summary":"本次会议是继2025年7月8日大西洋标准时间晚8点召开的股东特别大会之后召开的首场董事会会议。会议共有10位新任董事中的8位出席,另有一位因行程冲突未能参会的新董事也表达了对本次会议和董事会的支持。在会议议程的第一项中,与会董事一致选举赛富基金管理合伙人阎焱先生担任董事会主席。为此,董事会郑重声明,任何个人或实体如未获董事会或管理层正式授权,不得以公司名义行事。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710232614a6a1e9fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710232614a6a1e9fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2550619534","title":"科兴生物商业版图盘点","url":"https://stock-news.laohu8.com/highlight/detail?id=2550619534","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550619534?lang=zh_cn&edition=fundamental","pubTime":"2025-07-10 15:21","pubTimestamp":1752132087,"startTime":"0","endTime":"0","summary":"天眼查App显示,科兴生物关联公司北京科兴生物制品有限公司成立于2001年4月,法定代表人为尹卫东,注册资本约1.41亿人民币,经营范围含药品生产、药品批发、药品进出口、医学研究和试验发展、货物进出口等。司法案件信息显示,该公司涉及多起案件,包括股东知情权纠纷、公司决议纠纷、医疗损害责任纠纷等。商业履历信息显示,科兴生物董事长尹卫东名下关联20余家企业,其中18家为存续状态,包括北京科兴益道医药有限公司、北京兴益鼎生物技术有限公司、科兴中维(海南)生物技术有限公司等,尹卫东在上述公司担任执行董事、法定代表人等。(责任编辑:刘静 HZ010)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710153612a441fc50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710153612a441fc50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2550074618","title":"10位新董事上任,科兴生物特别股东大会通过赛富议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2550074618","media":"广州日报","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550074618?lang=zh_cn&edition=fundamental","pubTime":"2025-07-10 14:41","pubTimestamp":1752129708,"startTime":"0","endTime":"0","summary":"7月9日,SAIFPartners(赛富投资基金)公告称,在科兴控股生物技术有限公司(简称“科兴生物”)特别股东大会上,股东投票通过了SAIFPartners提出的两项议案:罢免该公司现任董事,并选举SAIFPartners提名的10位资深董事候选人进入公司董事会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202507103453279939.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2550618611","title":"疫苗之王科兴生物拟分红近540亿!张雪峰灵魂拷问:要给哪国的股民发我们当年的钱","url":"https://stock-news.laohu8.com/highlight/detail?id=2550618611","media":"快科技","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550618611?lang=zh_cn&edition=fundamental","pubTime":"2025-07-10 14:22","pubTimestamp":1752128574,"startTime":"0","endTime":"0","summary":"7月10日消息,疫苗之王科兴生物近日召开了特别股东大会,公司的董事会大洗牌!此外,科兴生物抛出总额最高75亿美元的“清仓式”分红方案,被市场视为争夺股东支持的策略,也可能意在掏空现金以削弱对手未来控制权。新董事会承诺推动复牌并落实分红,但维梧资本等股东仍以诉讼质疑其合法性,科兴生物未来仍充满不确定性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710143040953d17bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710143040953d17bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2550801661","title":"科兴生物特别股东大会选举10位新董事;多家医药上市公司发半年度预增公告 | 医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2550801661","media":"每日经济新闻","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550801661?lang=zh_cn&edition=fundamental","pubTime":"2025-07-10 07:21","pubTimestamp":1752103281,"startTime":"0","endTime":"0","summary":"丨2025年7月10日星期四丨NO.1甘李药业2025年半年度净利润预计翻番7月9日,甘李药业发布2025年半年度业绩预增公告,预计2025年半年度实现归母净利润6亿元到6.4亿元,同比增加100.73%到114.12%。公司表示主要受益于营业收入显著提升及费用的精细化管控。通过两轮胰岛素集采,公司成功实现扩大市场份额的战略目标。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202507103452616428.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202507103452616428.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","SVA","09939","BK4139","BK1161","BK1574"],"gpt_icon":0},{"id":"2550631970","title":"每股分红55美元 科兴生物出现“清仓式”分红计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2550631970","media":"中科财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550631970?lang=zh_cn&edition=fundamental","pubTime":"2025-07-09 19:03","pubTimestamp":1752059002,"startTime":"0","endTime":"0","summary":"控制权博弈持续七年再升级最近,科兴生物因“清仓式”分红计划被大众关注。6月18日,科兴生物宣布加快支付其此前每股派息55美元的分红计划。2016年,科兴生物计划私有化退市并回国上市。今年1月,与潘爱华联手的1Globe迎来转机,英国枢密院裁定科兴生物2018年股东大会程序违规,“毒丸计划”无效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709190910a4403c5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709190910a4403c5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVA"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":42,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SVA\",params:#limit:5,,,undefined,":[{"date":"2025-07-08","symbol":"SVA","amount":55,"announcedDate":"2025-04-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-23","defaultRemindTime":1751981400000,"name":"科兴生物","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-05-23","currency":"USD","dateTimestamp":1751947200000,"payDate":"2025-07-07"},{"market":"US","date":"2022-04-29","symbol":"SVA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1651204800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2021-12-31","symbol":"SVA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1640926800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2021-09-17","symbol":"SVA","fiscalQuarterEnding":"2021/06","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1631851200000,"reportTimeType":"post","actualEps":-0.05},{"market":"US","date":"2021-06-29","symbol":"SVA","fiscalQuarterEnding":"2021/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1624939200000,"reportTimeType":"","actualEps":-0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SVA\",market:\"US\",,,undefined,":[{"executeDate":"2025-07-08","recordDate":"2025-05-23","paymentDate":"2025-07-07","value":55,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SVA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SVA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SVA","date":"2021-09-21","current":5.82081,"percent":0.24257,"low":-100.201212,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"high":42.074882,"avg":0.136365,"sd":42.133061,"marketCap":642436987},"quantilePoints":[{"date":"2020-08-07","current":17.165727,"twenty":-59.560853,"median":24.555223,"eighty":133.776731,"marketCap":639903982},{"date":"2020-08-14","current":17.165727,"twenty":-59.560853,"median":24.431985,"eighty":132.906863,"marketCap":639903982},{"date":"2020-08-21","current":17.165727,"twenty":-59.560853,"median":24.370365,"eighty":42.074882,"marketCap":639903982},{"date":"2020-08-28","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":42.074882,"marketCap":639903982},{"date":"2020-09-04","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":42.074882,"marketCap":639903982},{"date":"2020-09-11","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":42.074882,"marketCap":639903982},{"date":"2020-09-18","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":42.074882,"marketCap":639903982},{"date":"2020-09-25","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":39.649553,"marketCap":639903982},{"date":"2020-10-02","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-10-09","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-10-16","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-10-23","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-10-30","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-11-06","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-11-13","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-11-20","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-11-27","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-12-04","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-12-11","current":25.871431,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-12-18","current":25.871431,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-12-24","current":25.871431,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-12-31","current":25.871431,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2021-01-08","current":25.871431,"twenty":-60.664761,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-01-15","current":25.871431,"twenty":-60.664761,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-01-22","current":25.871431,"twenty":-60.664761,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-01-29","current":25.871431,"twenty":-60.664761,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-02-05","current":25.871431,"twenty":-61.668314,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-02-12","current":25.871431,"twenty":-61.668314,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-02-19","current":25.871431,"twenty":-61.668314,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-02-26","current":25.871431,"twenty":-61.668314,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-03-05","current":25.871431,"twenty":-61.894113,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-03-12","current":25.871431,"twenty":-61.668314,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-03-19","current":25.871431,"twenty":-61.894113,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-03-26","current":25.871431,"twenty":-61.668314,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-04-01","current":25.871431,"twenty":-61.668314,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-04-09","current":25.871431,"twenty":-61.894113,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-04-16","current":25.871431,"twenty":-61.894113,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-04-23","current":5.79786,"twenty":-61.894113,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-04-30","current":5.82081,"twenty":-61.894113,"median":24.171596,"eighty":29.57901,"marketCap":642436987},{"date":"2021-05-07","current":5.82081,"twenty":-61.894113,"median":24.081398,"eighty":29.57901,"marketCap":642436987},{"date":"2021-05-14","current":5.82081,"twenty":-61.894113,"median":23.985687,"eighty":29.57901,"marketCap":642436987},{"date":"2021-05-21","current":5.82081,"twenty":-61.894113,"median":23.781276,"eighty":29.57901,"marketCap":642436987},{"date":"2021-05-28","current":5.82081,"twenty":-61.894113,"median":23.705864,"eighty":29.57901,"marketCap":642436987},{"date":"2021-06-04","current":5.82081,"twenty":-61.894113,"median":23.662388,"eighty":29.57901,"marketCap":642436987},{"date":"2021-06-11","current":5.82081,"twenty":-61.894113,"median":23.535556,"eighty":29.57901,"marketCap":642436987},{"date":"2021-06-18","current":5.82081,"twenty":-61.894113,"median":23.44385,"eighty":29.57901,"marketCap":642436987},{"date":"2021-06-25","current":5.82081,"twenty":-62.119913,"median":23.213593,"eighty":29.57901,"marketCap":642436987},{"date":"2021-07-02","current":5.82081,"twenty":-62.119913,"median":22.996932,"eighty":29.57901,"marketCap":642436987},{"date":"2021-07-09","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-07-16","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-07-23","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-07-30","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-08-06","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-08-13","current":5.82081,"twenty":-61.894113,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-08-20","current":5.82081,"twenty":-61.894113,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-08-27","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-09-03","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-09-10","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-09-17","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-09-24","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-10-01","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-10-08","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-10-15","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-10-22","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-10-29","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-11-05","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-11-09","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987}],"updateTime":1754549930353}}}